CSIMarket
 


Soleno Therapeutics Inc  (SLNO)
Other Ticker:  
 

Cumulative Soleno Therapeutics Inc's Working Capital Ratio for Trailing Twelve Months Period

SLNO's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

SLNO Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth 577.88 % 36.42 % 21.55 % -8.57 % -17.1 %
Y / Y Current Assets Growth 160.84 % -17.64 % -69.55 % -30.22 % -28.78 %
Working Capital Ratio for Trailing Twelve Months Period 2.34 3.76 4.35 5.91 6.2
Total Ranking # 1892 # 1810 # 1730 # 1521 # 1475
Seq. Current Liabilities Growth 466.27 % 22.17 % 6.48 % -7.97 % 13.96 %
Seq. Current Assets Growth 161.78 % 124.59 % -41.67 % -23.94 % -17.35 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to doubling in Current Liabilities in the III. Quarter to $29 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 2.34 below Soleno Therapeutics Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 150 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Soleno Therapeutics Inc. While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about SLNO
Working Capital Ratio SLNO in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 151
Sector # 739
S&P 500 # 1912


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
8.19 4.79 1.87
(Mar 31 2019)   (Sep 30 2023)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Glaukos Corp  6.41 
Outset Medical Inc   6.28 
Vivani Medical Inc   6.26 
Nexgel Inc   6.18 
Staar Surgical Company  6.17 
Venus Concept Inc   6.14 
Cardiovascular Systems Inc   6.13 
Anika Therapeutics Inc   6.11 
Conformis inc   6.09 
Microbot Medical Inc   6.05 
Alphatec Holdings Inc   5.95 
Orthopediatrics Corp  5.93 
Tandem Diabetes Care Inc   5.90 
Orasure Technologies Inc  5.68 
Globus Medical Inc   5.66 
Meihua International Medical Technologies Co Ltd   5.60 
Treace Medical Concepts Inc   5.57 
Penumbra Inc   5.55 
Dariohealth Corp   5.51 
Tela Bio Inc   5.50 
Electromed Inc   5.48 
Apyx Medical Corporation  5.42 
Perspective Therapeutics Inc   5.37 
Beyond Air Inc   5.28 
Acutus Medical Inc   5.22 
Predictive Oncology Inc   5.21 
Ir med Inc   5.10 
Intuitive Surgical Inc   5.02 
Bluejay Diagnostics Inc   4.98 
Inogen Inc   4.94 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com